secwatch.observer — SEC 8-K summary
======================================

Issuer:     DocGo Inc. (DCGO)
CIK:        0001822359
Form:       8-K
Filed at:   2024-11-07T23:59:59+00:00
Accession:  0001822359-24-000092
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DocGo Q3 2024 revenue falls 26% to $138.7M; raises FY2024 cash flow guidance to $90-100M
--------------------------------------------------------------------------------

- Q3 revenue $138.7M (-26% YoY) from migrant program wind down; net income $4.5M (flat YoY).
- Adjusted EBITDA $17.9M (+7% YoY); adjusted gross margin improved to 36.0% from 29.5%.
- FY2024 revenue guidance tightened to $620-630M; adj. EBITDA guided to $70-75M; cash flow ops raised to $90-100M.
- FY2025 revenue expected $410-450M with adj. EBITDA margin of 8%-10%.
- Care gap closure patients >500k; expanded West Coast operations; Dr. Stephen Klasko appointed board chair.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822359/000182235924000092/0001822359-24-000092-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822359/000182235924000092/dcgo-20241107.htm
  HTML page:      https://secwatch.observer/filing/0001822359-24-000092

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer